The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
This transaction fundamentally strengthens Scinai's CDMO platform
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
Subscribe To Our Newsletter & Stay Updated
